Test Price
2,800 AED✅ Home Collection Available
SOHLH1 Gene Oogenesis Dysfunction Genetic Test in UAE
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189 accredited NGS processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary telephonic post-test guidance with a Consultant Medical Geneticist to interpret results.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
Executive Summary & Core Metrics
The SOHLH1 gene oogenesis dysfunction test is a comprehensive genetic analysis for women experiencing primary ovarian insufficiency or unexplained infertility. Utilizing next‑generation sequencing (NGS), this test detects all pathogenic and novel variants in the SOHLH1 gene, which is critical for oocyte development. Results aid in clinical management and family planning.
Test Overview & Methodology
Our advanced NGS approach covers the full coding region and splice sites of the SOHLH1 gene, providing 99.9% diagnostic sensitivity. This method outperforms traditional Sanger sequencing in variant detection breadth.
| Feature | Our NGS Test | Sanger Sequencing Alternative |
|---|---|---|
| Analytical Method | Full coding region NGS (99.9% sensitivity) | Targeted single‑exon analysis (lower sensitivity) |
| Turnaround Time | 3–4 Weeks | 1–2 Weeks (limited coverage) |
| Variant Coverage | All known pathogenic and novel variants | Pre‑defined hotspot mutations only |
Physician Insight & Safety Protocols
"As a Consultant Medical Geneticist, I strongly recommend that every patient undergoing this test receives pre‑ and post‑test genetic counselling. The results must be interpreted within the full clinical context including family history and hormonal profile. Genetic findings alone do not constitute a treatment plan."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory on Result Interpretation
This genetic test is a diagnostic tool and must not be used as a standalone substitute for a complete reproductive evaluation. Patients should continue all prescribed medications unless otherwise directed by their treating physician. If you experience severe pelvic pain, bloating, or symptoms suggestive of ovarian hyperstimulation, seek immediate medical attention.
Patient Exclusion Criteria
- Not suitable for individuals currently on anticoagulant therapy without prior haematological clearance.
- Exclusion if active infection, dermatitis, or bruising is present at the venipuncture site.
- Emergency Red Flags: Seek urgent medical care if sudden abdominal pain, severe swelling, or signs of a systemic allergic reaction occur after sample collection.
Patient FAQ & Clinical Guidance
1. What is the role of the SOHLH1 gene in female fertility?
SOHLH1 gene mutations impair oocyte development, leading to primary ovarian insufficiency and infertility in women. This NGS test identifies both known and novel pathogenic variants to guide clinical management.
2. How accurate is this genetic test for oogenesis dysfunction?
With 99.9% diagnostic sensitivity, our NGS methodology detects all disease‑causing SOHLH1 variants with high precision, including rare novel mutations that Sanger sequencing may miss.
3. Do I need genetic counselling before the SOHLH1 test?
Yes, pre‑test genetic counselling is mandatory for all patients in the UAE to discuss implications, pedigree analysis, and result interpretation. Our genetics team provides complimentary counselling as part of the service.
UAE Regulatory & Data Privacy Adherence
Data Protection: All genetic data is processed in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Clinical Safety & Consent: Patient safety and informed consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Results are released only to the ordering physician with explicit patient consent.
Clinical & Logistical Metadata
| Test Name | SOHLH1 Gene Oogenesis Dysfunction Genetic Test (NGS) |
| Price (AED) | 2800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (3–5 mL in EDTA tube) |
| Methodology Used | Next‑Generation Sequencing (NGS) – full coding region & splice sites |
| ICD-10-CM Code | E28.3 (Primary ovarian failure), N97.0 (Female infertility associated with anovulation) |
| LOINC Code | 94138-2 (SOHLH1 gene mutation analysis) |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE Corporate Lab Branding: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians